Children’s use of pseudoephedrine
This article was originally published in The Tan Sheet
Executive Summary
Children younger than 2 years old are often given pseudoephedrine products, according to a study in the Dec. 1 Pediatrics journal. Researchers with the Slone Epidemiology Center at Boston University found 214 out of 4,267 children under the age of 17 surveyed between 1999 and 2006 took pseudoephedrine products - mostly in the form of multiple-ingredient liquids (58.9 percent) and multiple-ingredient tablets (24.7 percent). Use has declined since the institution of the 2005 Combat Methamphetamine Epidemic Act, researchers add
You may also be interested in...
Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development
Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.